Advancing preclinical cancer models to assess clinically relevant outcomes

Anna Golebiewska, Ryan C. Fields

Research output: Contribution to journalEditorial

1 Scopus citations

Abstract

Cancer models are indispensable research tools for elucidating the mechanisms involved in tumor onset, progression and treatment resistance. They are key in evaluating therapeutics prior clinical trials. In this editorial, we invite contributions for a BMC Cancer’s Collection of articles addressing ‘Advances in pre-clinical cancer models’ towards relivable outcomes at the preclinical stage.

Original languageEnglish
Article number230
JournalBMC Cancer
Volume23
Issue number1
DOIs
StatePublished - Dec 2023

Fingerprint

Dive into the research topics of 'Advancing preclinical cancer models to assess clinically relevant outcomes'. Together they form a unique fingerprint.

Cite this